Dr Bentz is presently affiliated with the Biology Department, College of General Studies, University of Pennsylvania, Kennett Square, PA. Dr Wilkins is presently affiliated with the Department of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois, Urbana, IL. A portion of these data were presented in abstract at the 2005 International Veterinary Emergency and Critical Care Meeting in Atlanta, Georgia and the 2005 Havemeyer Foundation Workshop on Uterine Infection in Mares and Women: A Comparative Study II in Hilton Head, South Carolina.
Prospective Evaluation of Coagulation in Critically Ill Neonatal Foals
Article first published online: 27 NOV 2008
Copyright © 2008 by the American College of Veterinary Internal Medicine
Journal of Veterinary Internal Medicine
Volume 23, Issue 1, pages 161–167, January/February 2009
How to Cite
Bentz, A.I., Palmer, J.E., Dallap, B.L., Wilkins, P.A. and Boston, R.C. (2009), Prospective Evaluation of Coagulation in Critically Ill Neonatal Foals. Journal of Veterinary Internal Medicine, 23: 161–167. doi: 10.1111/j.1939-1676.2008.0229.x
- Issue published online: 6 JAN 2009
- Article first published online: 27 NOV 2008
- Submitted March 30, 2008; Revised June 19, 2008; September 18, 2008; Accepted October 10, 2008.
- Septic shock
Background: Coagulopathy is a potentially underrecognized complication of sepsis and septic shock in critically ill neonatal foals.
Hypothesis: Critically ill neonatal foals have abnormalities in coagulation that are associated with disease severity and outcome.
Animals: Foals <72 hours old admitted to a neonatal intensive care unit.
Methods: Prospective, observational study. Blood was collected at admission, 24, and 48 hours for platelet count, prothrombin time, activated partial thromboplastin time, antithrombin activity and concentrations of fibrin degradation products, and fibrinogen in plasma from all foals.
Results: Sixty-three foals were enrolled and classified as Septic Shock (12), Septic (28), and Other (23). At least 1 abnormal value was found in 18/28 (64%) samples from the Septic Shock group, 66/85 (78%) from the Septic group, and 30/59 (51%) from the Other group (P= .01). Coagulopathy (3 or more abnormal values) was present in 7/28 (25%) samples in the Septic Shock group, 14/85 (16%) samples in the Septic group, and 3/59 (5%) samples in the Other group (P= .0028). Clinically detectable bleeding occurred in 8/12 (67%) Septic Shock cases, 11/28 (39%) Septic cases, and 3/23 (13%) Other cases (P= .009). Foals in Septic Shock were 12.7 times more likely to have clinical evidence of bleeding than those in the Other group (95% CI 2.3–70, P= .004). Treatment with fluids or plasma did not have a detectable effect on coagulation values.
Conclusions and Clinical Importance: Coagulopathy commonly occurs in critically ill neonatal foals, especially those with sepsis and septic shock.